×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Buyback Wednesdays – A Net-Net Biotech Announces A Large Buyback

  • June 1, 2022

With earnings season mostly behind us, buyback announcements also declined with a total of 18 companies announcing stock buybacks this week compared to 38 companies in the prior week. The top buyback is a nano-cap company with a market cap below $50 million that also happens to be a net-net. A net-net is a company where its market cap is less than current assets minus total liabilities.

Tonix Pharmaceuticals (TNXP) announced a $12.5 million buyback yesterday that represented more than a fourth of the company’s market cap at announcement. The company is a clinical-stage biotech that has one Phase 3 candidate for Fibromyalgia in its pipeline. The same drug will also enter Phase 2 trials as a potential treatment for Long COVID in Q2 2022. Beyond Fibromyalgia and Long COVID, the company also targets other central nervous system disorders and infectious diseases.

Please subscribe for free or login to your InsideArbitrage account to access this article.